A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease

American Heart Journal

Volumn 162, Issue 4, 2011, Pages 740-747

  Kufner, Sebastian ^a   De Waha, Antoinette ^a   Tomai, Fabrizio ^b   Park, Seong Wook ^c   Lee, Seung Whan ^c   Lim, Do Sun ^d   Kim, Moo Hyun ^e   Galloe, Anders M ^f   Maeng, Michael ^g   Briguori, Carlo ^h   Dibra, Alban ^a   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b EUROPEAN HOSPITAL   (Italy)

^c University of Ulsan College of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Dong A University College of Medicine   (South Korea)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h Clinica Mediterranea   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; RISK REDUCTION; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION;

CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; HUMANS; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS;

EID: 80053630382     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.07.003     Document Type: Article

References (29)

1. S. Elezi, A. Kastrati, and J. Pache Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J Am Coll Cardiol 32 1998 1866 1873 (Pubitemid 29010448)
2. L.O. Jensen, M. Maeng, and P. Thayssen Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark Am J Cardiol 105 2010 1513 1519
3. Barry A, Wilkinson I, Halford V, et al. A clinical study and the national service framework for diabetes. J Tissue Viability 2004;14:124, 126, 128, passim.
4. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
5. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
6. D.J. Kereiakes, D.E. Cutlip, and R.J. Applegate Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) J Am Coll Cardiol 56 2010 2084 2089
7. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670 (Pubitemid 41175674)
8. M.H. Kim, S.J. Hong, and K.S. Cha Effect of paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients J Interv Cardiol 21 2008 225 231 (Pubitemid 351703982)
9. M. Maeng, L.O. Jensen, and A.M. Galloe Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol 103 2009 345 349
10. S.W. Lee, S.W. Park, and Y.H. Kim A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol 52 2008 727 733
11. F. Tomai, B. Reimers, and L. De Luca Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study Diabetes Care 31 2008 15 19
12. C. Briguori, F. Airoldi, and G. Visconto Novel approaches for Preventing or Limiting events in diabetic patients (NAPLES-DIABETES) trial: a randomized comparison of three drug-eluting stents in diabetic patients Circ Cardiovasc Interv 4 2011 121 129
13. S. Greenland Invited commentary: a critical look at some popular meta-analytic methods Am J Epidemiol 140 1994 290 296
14. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46 (Pubitemid 32682008)
15. P. Juni, A. Witschi, and R. Bloch The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060 (Pubitemid 29436453)
16. A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
17. D.J. Kumbhani, A.A. Bavry, and A.R. Kamdar The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials Am Heart J 155 2008 640 647
18. E. Mahmud, G. Bromberg-Marin, and V. Palakodeti Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis J Am Coll Cardiol 51 2008 2385 2395 (Pubitemid 351815166)
19. G. Patti, A. Nusca, and G. Di Sciascio Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus Am J Cardiol 102 2008 1328 1334
20. A. Schomig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380 (Pubitemid 47449734)
21. Stettler C., Allemann S., and Wandel S. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis BMJ 337 2008 a1331
22. M. Maeng, L.O. Jensen, and A. Kaltoft Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus Am J Cardiol 102 2008 165 172
23. W.M. Wolf, H.A. Vlachos, and O.C. Marroquin Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry Circ Cardiovasc Interv 3 2010 42 49
24. F. Zhang, L. Dong, and J. Ge Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus Am J Cardiol 105 2010 64 68
25. A. Abizaid, R. Kornowski, and G.S. Mintz The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589 (Pubitemid 28435240)
26. C. Patterson, S. Mapera, and H.H. Li Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling Arterioscler Thromb Vasc Biol 26 2006 1473 1480 (Pubitemid 44288971)
27. N. Millauer, P. Juni, and A. Hofmann Sirolimus versus paclitaxel coronary stents in clinical practice Catheter Cardiovasc Interv 77 2010 5 12
28. A.J. Kirtane, R. Patel, and C. O'Shaughnessy Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease JACC Cardiovasc Interv 2 2009 967 976
29. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)